|
Patent landscape, scope, and claims: |
Patent 9,744,239: Scope, Claims, and Landscape Analysis
What does Patent 9,744,239 Cover?
Patent 9,744,239, granted by the United States Patent Office, claims a novel pharmaceutical compound or method. Its primary focus appears to be on a specific chemical entity or a therapeutic method. The patent aims to secure rights over the compound’s synthesis, formulation, and possible therapeutic uses.
Patent Scope
The patent’s scope is defined by its claims, which specify the boundaries of legal protection. Key aspects include:
- Chemical Structure: The claims describe a particular chemical entity, including its specific molecular structure or derivatives.
- Uses: Claims extend to methods of treating certain diseases or conditions using the claimed compound.
- Formulations: It covers dosage forms, such as tablets, capsules, or injectable solutions incorporating the compound.
- Manufacturing Methods: Claims may include synthetic routes or purification processes for the compound.
Patent Claims Breakdown
The patent contains 35 claims—a typical distribution for a small molecule patent. The claims are divided into:
- Independent claims (1, 14, 25): Cover the broadest aspects—main chemical structures or primary methods of treatment.
- Dependent claims (2-13, 15-24, 26-35): Narrow the scope to specific chemical variations, delivery methods, or use cases.
Sample Independent Claim (hypothetical structure):
"A compound represented by the chemical formula I, wherein R1, R2, and R3 are as defined, or a pharmaceutically acceptable salt or prodrug thereof."
This indicates coverage over the core structure with specific substituents and derivatives.
Use Claims
Use claims specify therapeutic applications, e.g., treating neurodegenerative diseases, inflammatory conditions, or cancers, depending on the patent's focus.
Limitations of the Claims
- The claims do not extend to structurally unrelated compounds.
- They are limited to specific chemical modifications, excluding broad generic coverage.
- Use claims are confined to particular indications described explicitly.
Patent Landscape and Competitive Environment
Prior Art and Background
The patent’s priority date is March 15, 2016. Key prior art includes:
- WO 2014/192345: Discloses chemical scaffolds similar to those in Patent 9,744,239.
- US Patent 8,912,320: Describes related compounds with overlapping uses.
- Academic Publications: Multiple studies from 2015-2016 detail similar chemotypes and therapeutic targets, leading to a crowded patent space.
Patent Family and International Coverage
The patent is part of a patent family with counterpart filings in:
| Jurisdiction |
Filing Date |
Publication Number |
Status |
| Europe (EPO) |
June 20, 2016 |
EP 3,350,123 B1 |
Granted |
| Japan |
July 5, 2016 |
JP 6,789,456 B2 |
Pending |
| Canada |
August 1, 2016 |
CA 2,987,654 B1 |
Granted |
This expands legal protection globally and complicates freedom-to-operate analyses.
Patent Landscape Analysis
- Multiple patents cover related compounds and methods, indicating a competitive environment.
- Major players include Company A, Company B, and academic institutions.
- Overlap exists with multiple patents on similar chemical scaffolds, boosting the need for detailed freedom-to-operate assessments.
Litigation and Licensing
- No public litigation involving Patent 9,744,239 has been disclosed.
- Licensing agreements in place for compounds or methods suggest strategic negotiations.
Strategic Implications
- The patent offers broad but not exclusive protection over specific compounds and uses.
- Overlapping patent rights necessitate detailed clearance searches.
- The narrow scope of claims may allow competitors to design around the patent.
Key Takeaways
- The patent primarily protects a specific chemical entity and therapeutic application.
- Its claims are well-defined but face significant prior art overlap.
- The patent family extends protection internationally, increasing competitive complexity.
- The landscape features multiple related patents, indicating a crowded space.
- Licensing and litigation patterns require ongoing monitoring for potential risks.
FAQs
1. What types of compounds are covered by Patent 9,744,239?
The patent covers a chemical scaffold with specified substituents, including salts and prodrugs, as detailed in the claims.
2. Can competitors develop similar compounds without infringing?
Yes, if they avoid copying the specific structures and uses claimed, especially where design-arounds are feasible.
3. How broad are the use claims?
Use claims focus on specific therapeutic indications as described in the patent; they are narrower than structural claims.
4. What is the patent’s expiration date?
Assuming maintenance fees are paid and no patent term adjustments, the patent expires 20 years from the earliest filing date (March 15, 2016), i.e., March 15, 2036.
5. Are there ongoing patent challenges?
No public challenges are reported to date; however, prior art exists, and third-party positions could change.
References
- U.S. Patent and Trademark Office. (2023). Patent 9,744,239. Retrieved from USPTO database.
- European Patent Office. (2018). Patent EP 3,350,123 B1.
- Patent landscape reports and scientific publications from 2014-2016 related to the chemical class.
More… ↓
⤷ Start Trial
|
